Awareness of toxic positivity can help patients and caregivers build resilience and hope that will support them throughout ...

Although this was a negative study, I think the data shown here contribute to our knowledge of IO treatments in urothelial cancer,” said Michiel Van der Heijden, MD, PhD.

CLL-314 trial compared the efficacy and safety of pirtobrutinib with ibrutinib in adults with CLL/SLL who were treatment-naïve or who were previously treated and were BTK inhibitor-naïve.

The study results “indicate that the public has certain reservations about the integration of AI in health care,” the researchers wrote.

HealthDay News — Cannabis use disorder (CUD) is associated with an increased risk for oral cancer, according to a study published in the September issue of Preventive Medicine Reports.

Researchers investigated the long-term of safety and efficacy of subcutaneously injected pertuzumab and trastuzumab in patients with HER2-positive early breast cancer.

Researchers sought to determine whether daratumumab monotherapy could be effective in delaying progression of SMM.